[1]Scarpati;Oriente[Tetrahedron,1958,vol.4,p.43,44,45]
[1]Tetrahedron,1958,vol.4,p.43,44,45
[1]Zhao,He;BurkeJr.,TerrenceR.[SyntheticCommunications,1998,vol.28,#4,p.737-740]
[1]Lamidey,Anne-Marie;Fernon,Lionel;Pouysegu,Laurent;Delattre,Charlotte;Quideau,Stephane;Pardon,Patrick[HelveticaChimicaActa,2002,vol.85,#8,p.2328-2334]
[1]Lamidey,Anne-Marie;Fernon,Lionel;Pouysegu,Laurent;Delattre,Charlotte;Quideau,Stephane;Pardon,Patrick[HelveticaChimicaActa,2002,vol.85,#8,p.2328-2334]
Title: Reinke RA, et al. L-chicoric acid inhibits human immunodeficiency virus type 1 integration in vivo and is a noncompetitive but reversible inhibitor of HIV-1 integrase in vitro. Virology. 2004 Sep 1;326(2):203-19.
Title: King PJ, et al. Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase. J Virol. 1998 Oct;72(10):8420-4.
Title: Robinson WE Jr. L-chicoric acid, an inhibitor of human immunodeficiency virus type 1 (HIV-1) integrase, improves on the in vitro anti-HIV-1 effect of a protease inhibitor (AG1350). Antiviral Res. 1998 Aug;39(2):101-11.